文献速递颅颌面外科美容整形

Beckwith-Wiedemann综合征患者自报言语结局

Patient-Reported Speech Outcomes in Patients with Beckwith-Wiedemann Syndrome.
PubMed 文献 · Plast Reconstr Surg · 2026-03-10

结果显示整体结局良好,但言语功能评分相对较低,且言语治疗与较低言语功能相关,手术与否及巨舌指数(BIG)无显著差异。

要点

  • BWS患者自报言语功能评分较低,提示持续言语挑战。
  • 接受言语治疗者言语功能评分更低,手术与否无显著差异。
  • ICS评分与言语功能中度相关,需个体化纵向管理。

核心结论

  • BWS患者整体自报结局良好,但言语功能评分较低,提示该人群存在持续言语挑战。

主要发现

  • FACE-Q平均分:言语痛苦84.7±15.0,呼吸84.9±15.0,进食饮水80.9±15.9,面部功能92.0±12.1,言语功能75.8±19.5。
  • ICS评分与言语功能中度相关(r=0.697,p=0.001)。
  • 在学校和临床接受言语治疗者言语功能评分更低(p=0.014)。
  • 手术与非手术患者间及不同BIG评分间无显著差异(p>0.1)。

临床怎么用

  • 应关注BWS患者言语功能,即使整体结局良好,仍需个体化纵向管理。
  • 言语治疗与较低言语功能相关,提示需评估治疗指征及效果。

局限性

  • 为前瞻性自报结局研究,未设对照组,因果推断受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Macroglossia is a hallmark feature of Beckwith-Wiedemann Syndrome (BWS) and may affect a child's appearance, speech, and feeding. Tongue reduction surgery (TRS) is often recommended to address functional concerns, but its effects on patient-reported speech outcomes remain unclear. This study evaluates self-reported speech outcomes in individuals with BWS. METHODS: Patients with BWS (aged 4-18 years) were prospectively administered the FACE-Q Craniofacial measures (speech distress, breathing, eating and drinking, facial function, speech function). Surveys were Rasch transformed score (0-100, 100=best outcome). Clinical characteristics, BWS Index of Macroglossia (BIG), and Intelligibility in Context Scale (ICS) scores were reviewed. RESULTS: Thirty-six patients (50% male; mean age 8.6±3.8 years at survey) were included. Most patients had an IC2-LOM genetic diagnosis (n=24, 66.6%). Average BIG score was 1.3±1.1 (range 0-3). Speech therapy was received by 28 patients (77.8%) and 16 (44.4%) underwent TRS at mean age 2.3±2.0 years. FACE-Q scores averaged 84.7±15.0 for speech distress, 84.9±15.0 for breathing, 80.9±15.9 for eating and drinking, 92.0±12.1 for facial function, and 75.8±19.5 for speech function. There was moderate correlation between ICS score and speech function (r=0.697, p=0.001). Patients who received speech therapy at school and clinically had lower speech function (p=0.014). No significant differences were found between surgical and non-surgical patients or by BIG scores (p>0.1). CONCLUSIONS: While overall reported outcomes were favorable, speech function scores were lower, suggesting persistent speech challenges in this population. These findings underscore the multifactorial nature of speech development in BWS and the importance of individualized, longitudinal management to optimize outcomes.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hu AC, George AM, Viswanathan A, et al. Patient-Reported Speech Outcomes in Patients with Beckwith-Wiedemann Syndrome. Plast Reconstr Surg. 2026. PMID: 41805692. doi:10.1097/PRS.0000000000013004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。